ClinConnect ClinConnect Logo
Search / Trial NCT02278640

Harmonic ACE®+7 Shears in Laparoscopic Hysterectomy

Launched by ETHICON ENDO-SURGERY · Oct 29, 2014

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

Study Population: Subjects enrolled into this study will undergo elective total laparoscopic hysterectomy for benign indications wherein dissection and transection of the uterine vasculature is indicated.

Primary Variables: Percentage of subjects achieving hemostasis at the named vessel/pedicle (UA or UP) on the left side. Percentage of subjects achieving hemostasis at the named vessel/pedicle (UA or UP) on the right side.

Definition: Hemostasis of the named vessel or pedicle is a dichotomous variable (i.e. yes or no). "Yes" is defined as the hemostatic transection of the uterine vasculat...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Subjects satisfying all of the following criteria will be considered the screening population and will be eligible for participation in this study:
  • 1. Indicated for elective total laparoscopic hysterectomy
  • 2. Age \>=40 years and no future desire for fertility
  • Exclusion Criteria:
  • Subjects with any of the following criteria will be excluded from the study:
  • Preoperative exclusion criteria:
  • 1. Known or suspected uncontrolled bleeding disorders
  • 2. Subjects unlikely to comply with protocol procedures or adhere to the study visit schedule
  • 3. Any condition rendering a subject unable to understand the nature, scope, and possible consequences of the study or study procedures
  • 4. Any Subject unwilling to sign the study informed consent document
  • 5. Any suspected malignancy
  • 6. Any Subject of childbearing potential with a positive or serum pregnancy test within 24 hours prior to surgery
  • Intra-operative exclusion criteria:
  • 7. Any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure

About Ethicon Endo Surgery

Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, is a leading global innovator in surgical devices and technologies, specializing in minimally invasive surgical solutions. With a commitment to advancing patient care, the company focuses on developing cutting-edge products that enhance surgical efficiency and improve patient outcomes. Ethicon Endo-Surgery conducts rigorous clinical trials to evaluate the safety and efficacy of its innovative devices, contributing to the evolution of surgical practices across various specialties. Through collaboration with healthcare professionals and ongoing research, the company aims to set new standards in surgical performance and patient safety.

Locations

Celebration, Florida, United States

Schaumburg, Illinois, United States

Nijmegen, , Netherlands

Surrey, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials